Zenobia Therapeutics, Inc.
505 Coast Boulevard South
Suite 111
La Jolla
California
92037
United States
Tel: 858-926-5780
Website: http://www.zenobiatherapeutics.com/
Email: info@zenobiatherapeutics.com
7 articles about Zenobia Therapeutics, Inc.
-
Zenobia Therapeutics, Inc. Announce a Partnership With the Alzheimer's Drug Discovery Foundation
8/14/2012
-
Zenobia Therapeutics, Inc. and BioBlocks, Inc. Announce Sale of a Joint Fragment Library Ideal for Screening by All Popular Methods
5/7/2012
-
Zenobia Therapeutics, Inc. Enters Into a Research Collaboration With Lundbeck Inc. for the Parkinson's Disease Target LRRK2
12/16/2010
-
Zenobia Therapeutics, Inc. Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals, Inc.
4/14/2009
-
Zenobia Therapeutics, Inc. Announces Sale of Commercial Fragment Library Ideal for Crystallographic, NMR and SPR Screening
3/2/2009
-
Zenobia Therapeutics, Inc. Receives The Michael J. Fox Foundation for Parkinson's Research Award for Work on PD-implicated Protein LRRK2
7/29/2008
-
Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
7/21/2008